ArticleEuropean journal of nuclear medicine and molecular imaging2017
Article in European journal of nuclear medicine and molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 66 citations in OpenAlex.
- Predictive value of metabolic parameters from PET/CT in adult multifocal Langerhans cell histiocytosis.Annals of nuclear medicine · 2026Article
- Age-Stratified Imaging Selection in Langerhans Cell Histiocytosis: Towards a Clinical Decision Framework.Journal of clinical medicine · 2026Article
- Diffuse cystic lung diseases-a primer for radiologists.BJR open · 2026Review
- Value of 18F-FDG PET/CT Scans in Staging and Follow-Up of Pediatric Langerhans Cell Histiocytosis: Comparison to CT and/or MRI.Children (Basel, Switzerland) · 2025Article
- [European journal of nuclear medicine and molecular imaging · 2025Article
- Langerhans cell histiocytosis of the suprasellar region: diagnosis based on thyroid cytology.European thyroid journal · 2024Article
- Diagnosis and treatment of isolated rib Langerhans cell histiocytosis in an adult: A case report.Frontiers in surgery · 2023Article
- Isolated Scapular Lesion of Langerhans Cell Histiocytosis Detected byMolecular imaging and radionuclide therapy · 2022Article
- Langerhans Cell Histiocytosis: A Population-based Study of Anatomical Distribution and Treatment Patterns.Journal of bone oncology · 2022Article
- Multisystem Langerhans cell histiocytosis: Literature review and case report.Radiology case reports · 2022Article
- Article
- Langerhans cell histiocytosis presenting as an isolated brain tumour: A case report.World journal of clinical cases · 2022Article
- Analysis of thyroid involvement in children and adult Langerhans cell histiocytosis: An underestimated endocrine manifestation.Frontiers in endocrinology · 2022Article
- Application ofContrast media & molecular imaging · 2022Article
- Skeletal staging in Langerhans cell histiocytosis: a multimodality imaging review.Skeletal radiology · 2021Review
- Role ofBMC endocrine disorders · 2020Article
- Update on Pulmonary Langerhans Cell Histiocytosis.Frontiers in medicine · 2020Review
- Association between clinicopathologic characteristics and BRAFThoracic cancer · 2019Article
- Comparison of whole-body MRI, bone scan, and radiographic skeletal survey for lesion detection and risk stratification of Langerhans Cell Histiocytosis.Scientific reports · 2019Article
- Oral manifestation of Langerhans cell histiocytosis: a case report.BMC oral health · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe standard evaluation of multisystem Langerhans cell histiocytosis (LCH) includes a clinical evaluation, laboratory tests and a skeleton/skull X-ray survey, with chest high-resolution computed tomography (HRCT) in the case of pulmonary involvement. Preliminary reports suggest that
methodsFourteen consecutive adult patients with multisystem LCH were included in this retrospective study, and were evaluated using standard procedures and
resultsAt the baseline evaluation, PET-CT identified every LCH localization found with the standard evaluation (except a mild cecum infiltration). PET-CT showed additional lesions in seven patients, mostly involving bones, and differentiated inactive from active lesions. Thyroid
conclusionsExcept for cases with pulmonary and pituitary involvement,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.